An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors
Clinical trial NCT03349073 · COMPLETED
Trial details
- NCT number
- NCT03349073
- Sponsor
- Taivex Therapeutics Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-14
- Primary completion
- 2019-06-24
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.